iTeos Therapeutics, Inc. (ITOS) has 20 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は EcoR1 Capital, LLC 7,388,978 株保有. その他の主要保有者には RA CAPITAL MANAGEMENT, L.P. および GADICKE ANSBERT.
過去12ヶ月間にインサイダーは 15 件の取引を実施 ITOS 株式 — 2 件の買い (評価額 $38.69M) および 10 件の売り (評価額 $21.47M). インサイダーの売りが買いを上回っています.
ITOS インサイダー保有状況
最大保有者
EcoR1 Capital, LLC
7,388,978 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Ecor1 Capital, Llc |
10 Percent Owner |
7,388,978 |
2025-05-16 |
|
| 2 |
Ra Capital Management, L.p. |
Other: Former 10% Owner |
5,714,285 |
2024-05-14 |
|
| 3 |
Gadicke Ansbert |
Other: Former 10% Owner |
3,452,797 |
2025-05-15 |
|
| 4 |
Lewis Joseph |
Director |
3,142,058 |
2022-03-18 |
|
| 5 |
Boxer Capital, Llc |
Other: See Remarks |
2,946,915 |
2024-05-14 |
|
| 6 |
Mpm Bioventures 2018, L.p. |
Other: Former 10% Owner |
2,108,594 |
2025-05-15 |
|
| 7 |
Mpm Bioventures 2014, L.p. |
Other: Former 10% Owner |
2,108,594 |
2025-05-15 |
|
| 8 |
Call Matthew |
Chief Operating Officer |
145,000 |
2025-03-11 |
|
| 9 |
Detheux Michel |
Chief Executive Officer |
135,903 |
2025-03-11 |
|
| 10 |
Lager Joanne Jenkins |
Chief Medical Officer |
130,000 |
2023-03-10 |
|
| 11 |
Gall Matthew |
Chief Financial Officer |
89,429 |
2025-03-11 |
|
| 12 |
Feltquate David |
Chief Medical Officer |
47,000 |
2024-12-06 |
|
| 13 |
Mcgrath Yvonne |
Chief Scientific Officer |
46,300 |
2025-03-11 |
|
| 14 |
Lee David K |
Director |
24,200 |
2024-06-13 |
|
| 15 |
Desimone Jill |
Director |
24,200 |
2024-06-13 |
|
| 16 |
Ho Tony W |
Director |
24,200 |
2024-06-13 |
|
| 17 |
Davis Aaron I. |
Director |
24,200 |
2024-06-13 |
|
| 18 |
Hallal David |
Director |
24,200 |
2024-06-13 |
|
| 19 |
Van Hauwermeiren Timothy |
Director |
24,200 |
2024-06-13 |
|
| 20 |
Rhoads Ann D |
Director |
24,200 |
2024-06-13 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2025-06-10 |
Detheux Michel |
Chief Executive Officer |
情報に基づく売り |
43,883 |
$10.02 |
$439.71K |
| 2025-06-09 |
Detheux Michel |
Chief Executive Officer |
情報に基づく売り |
43,882 |
$10.03 |
$440.14K |
| 2025-06-06 |
Detheux Michel |
Chief Executive Officer |
情報に基づく売り |
43,882 |
$10.21 |
$448.04K |
| 2025-06-05 |
Detheux Michel |
Chief Executive Officer |
情報に基づく売り |
43,882 |
$10.15 |
$445.4K |
| 2025-06-04 |
Detheux Michel |
Chief Executive Officer |
情報に基づく売り |
43,883 |
$10.10 |
$443.22K |
| 2025-06-06 |
Hallal David |
Director |
オプション行使（売却） |
38,228 |
$4.30 |
$164.38K |
| 2025-06-05 |
Hallal David |
Director |
情報に基づく売り |
38,227 |
$10.15 |
$388K |
| 2025-06-04 |
Hallal David |
Director |
情報に基づく売り |
38,227 |
$10.07 |
$384.95K |
| 2025-05-15 |
Ecor1 Capital, Llc |
10 Percent Owner |
情報に基づく買い |
3,300,000 |
$8.00 |
$26.4M |
| 2025-05-14 |
Ecor1 Capital, Llc |
10 Percent Owner |
情報に基づく買い |
1,658,978 |
$7.41 |
$12.29M |
| 2025-05-13 |
Mpm Bioventures 2018, L.p. |
Other: Former 10% Owner |
情報に基づく売り |
630,191 |
$8.06 |
$5.08M |
| 2025-05-13 |
Mpm Bioventures 2014, L.p. |
Other: Former 10% Owner |
情報に基づく売り |
630,191 |
$8.06 |
$5.08M |
| 2025-05-13 |
Gadicke Ansbert |
Other: Former 10% Owner |
情報に基づく売り |
1,031,931 |
$8.06 |
$8.32M |
| 2025-05-13 |
Van Hauwermeiren Timothy |
Director |
オプション行使（売却） |
22,346 |
$4.30 |
$96.09K |
| 2025-05-13 |
Ecor1 Capital, Llc |
10 Percent Owner |
不明 |
- |
- |
- |
